Optimizing the management of patients with relapsing forms of MS: An update on emerging treatment options

touchEXPERT OPINIONS for touchNEUROLOGY A leading multiple sclerosis (MS) specialist shares key considerations for a personalized treatment strategy for patients with relapsing forms of MS, and goes on to explore the key role that B cells play in the pathogenesis and progression of MS, including the therapeutic potential of B-cell–targeted agents. The expert Prof. Martin Weber, University Medical Center Göttingen, Germany This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME.  For further information visit: touchneurologyime.org/eo-update-on-optimizing-management-of-rms